about
Improved efficacy of alpha-particle-targeted radiation therapy: dual targeting of human epidermal growth factor receptor-2 and tumor-associated glycoprotein 72Preparation and in vivo evaluation of radioiodinated closo-decaborate(2-) derivatives to identify structural components that provide low retention in tissues.Dosimetry for radiopharmaceutical therapyAn overview of targeted alpha therapy.Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analoguesRadioimmunotherapy with α-particle-emitting radionuclides.Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.Imaging virus-associated cancer.Therapeutic Efficacy of Alpha-RIT Using a (213)Bi-Anti-hCD138 Antibody in a Mouse Model of Ovarian Peritoneal CarcinomatosisApplication of (212)Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.Targeted α-particle therapy of bone metastases in prostate cancerReceptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.Bismuth compounds in medicinal chemistry.Ablation of experimental colon cancer by intratumoral 224Radium-loaded wires is mediated by alpha particles released from atoms which spread in the tumor and can be augmented by chemotherapy.Differential gene expression in human fibroblasts after alpha-particle emitter (211)At compared with (60)Co irradiation.Transcriptional responses in irradiated and bystander fibroblasts after low dose α-particle radiation.Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.Unprecedented incorporation of α-emitter radioisotope 213Bi into porphyrin chelates with reference to a daughter isotope mediated assistance mechanism.LET-dependent bystander effects caused by irradiation of human prostate carcinoma cells with X rays or alpha particles.A unique alpha dosimetry technique using Gafchromic EBT3(®) film and feasibility study for an activity calibrator for alpha-emitting radiopharmaceuticals.Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells.[Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
P2860
Q28272255-DD157A89-62B6-4227-BD3F-7F01183B0F7CQ33657227-1D516162-F626-45E2-92E9-A705615D2456Q33665116-C107DAB4-489C-4CDF-BBD9-0F8D214DCDB1Q34238513-8C72C39E-4365-414A-ACEF-79975844C275Q34395062-7BCA40DA-2CC1-46BA-8043-DD01A489EE1BQ34419562-94EEDACB-AFDE-4C24-96A7-11B54AF2DFF8Q34460892-7ACDA6A8-DAAB-46A8-B93C-39F735C8F919Q34682223-EC4C0580-3101-4C6B-A6A0-A02C3ECD8082Q36015054-3FAD73F3-452D-4EE2-B0E0-BAE3151F43A7Q36387694-B15EB616-BB0E-4792-8AD1-A45A477FE789Q36551498-8BB9781C-449B-41AE-A3EF-D8A5DA2DCC8EQ37417656-231A8BD8-ED01-48A1-B667-E2A12C09B36BQ37515337-8C30AB8C-C03B-4500-9111-464B77085329Q37969746-811F6E5B-B705-46E5-88D1-63489EBF14ABQ38031636-8A24E199-09A0-4DFD-87CE-F84757C0C87CQ38960709-579E6C4E-C0C8-4F99-90F6-420863977FC6Q39248375-7242CAA0-F6E8-4BDC-A333-1868D48AD2DFQ39319377-305DF587-6C3B-4FAB-B033-AF956AAEE01AQ39486574-87C10502-D879-4F5D-9D84-12F4470A507AQ39516860-B1FE4A21-9985-4EE5-9E03-4F1E933E6D9AQ39913677-9B00F2A9-C242-4709-A4B4-C050075AFE15Q40462195-11EC79B5-D67F-4ACF-9CE6-6C5EDB7145DCQ42077750-5B8438D3-B188-4D9E-A6C9-11A48AEC9D22Q54025029-A72C61CA-2C0E-4BE5-9CA4-15FE2B0713F7
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Targeted alpha-therapy: past, present, future?
@ast
Targeted alpha-therapy: past, present, future?
@en
type
label
Targeted alpha-therapy: past, present, future?
@ast
Targeted alpha-therapy: past, present, future?
@en
prefLabel
Targeted alpha-therapy: past, present, future?
@ast
Targeted alpha-therapy: past, present, future?
@en
P2860
P356
P1433
P1476
Targeted alpha-therapy: past, present, future?
@en
P2093
Martin W Brechbiel
P2860
P304
P356
10.1039/B704726F
P407
P577
2007-09-11T00:00:00Z